Ensysce Biosciences Stock Investor Sentiment
| ENSC Stock | USD 3.71 0.17 4.38% |
About 61% of Ensysce Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Ensysce Biosciences suggests that many traders are alarmed. The current market sentiment, together with Ensysce Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ensysce Biosciences stock news signals to limit their universe of possible portfolio assets.
Ensysce |
Ensysce Biosciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Ensysce Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Ensysce Biosciences that are available to investors today. That information is available publicly through Ensysce media outlets and privately through word of mouth or via Ensysce internal channels. However, regardless of the origin, that massive amount of Ensysce data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ensysce Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ensysce Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ensysce Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ensysce Biosciences alpha.
Ensysce Biosciences Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Wright Richard Chester of 49975 shares of Ensysce Biosciences subject to Rule 16b-3 | 01/17/2025 |
2 | Short Interest in Ensysce Biosciences, Inc. Grows By 85.7 | 01/30/2025 |
3 | Acquisition by Gower Bob G of 7919026 shares of Ensysce Biosciences subject to Rule 16b-3 | 01/31/2025 |
4 | Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment | 02/05/2025 |
5 | Disposition of 8330 shares by Carrera Eric of Ensysce Biosciences subject to Rule 16b-3 | 02/28/2025 |
6 | Ensysce Biosciences to Participate in the 37th Annual ROTH Conference | 03/05/2025 |
7 | Acquisition by Martin Steven Robert of 65850 shares of Ensysce Biosciences at 3.35 subject to Rule 16b-3 | 03/07/2025 |
8 | Ensysce Biosciences Announces Quarterly Earnings Results, Misses Estimates By 0.16 EPS | 03/10/2025 |
9 | Ensysce Biosciences Full Year 2024 Earnings Beats Expectations | 03/12/2025 |
10 | Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. | 03/13/2025 |
11 | Ensysce Biosciences Announces PAINWeek 2025 Symposium and Recent Expert Panel Discussion on The State of the Nation in Pain | 03/18/2025 |
Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |